ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0720

Impact of Systemic Vasculitides on Sexual Function: An Overlooked Aspect of Patient Care

javier Merayo Chalico1, Ana Sarahí Mulia-Soto2, María Espinosa-León3, Victor Pimentel-Quiroz4, Ana Barrera-Vargas3 and Andrea Hinojosa-Azaola3, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, CDMX, Mexico, 2Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Ciudad de México, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Mexico, 4Universidad Científica del Sur/Hospital Nacional Guillermo Almenara Irigoyen, Magdalena del Mar, Peru

Meeting: ACR Convergence 2024

Keywords: Education, functional status, Patient reported outcomes, Sexual Function, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Vasculitis – ANCA-Associated Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic vasculitides comprise a group of inflammatory diseases involving multiple organ systems, significantly affecting various aspects of a patient’s life, including their sexuality. Sexual function is often overlooked during consultation, leading to its undervaluation. Both systemic and vascular inflammation cause tissue damage, impacting sexual function in both women and men. The aim of this study was to evaluate factors associated with sexual dysfunction in patients with different types of systemic vasculitides.

Methods: A cross-sectional study was conducted at two centers in Latin America (Mexico and Peru), including patients with systemic vasculitis (Takayasu’s arteritis, polyarteritis nodosa, granulomatosis with polyangiitis [GPA], microscopic polyangiitis [MPA], eosinophilic granulomatosis with polyangiitis, or IgA vasculitis) from October 2023 to May 2024. Demographic and disease-specific variables, comorbidities, and immunosuppressant doses were collected. Global assessments of the patient (PtGA) and physician (PhGA) were performed on scales from 0 to 100. Disease activity was evaluated using the Birmingham Vasculitis Activity Score version 3 (BVAS v.3) or definitions from the European League Against Rheumatism, and damage was assessed using the Vasculitis Damage Index (VDI). Sexual function was evaluated using the Spanish version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14), which assesses various domains associated with sexuality. Sexual dysfunction was defined by a score ≤41 points in women and ≤47 points in men.

Results: Fifty-five patients were included; 56% were women, with a mean age of 48.93 years (±11.5). The most common vasculitis was GPA (55% of patients), followed by MPA (24% of patients). The mean CSFQ-14 score was 40.91, with 62% of patients experiencing some degree of sexual dysfunction. Table 1 summarizes the characteristics of the patients with and without sexual dysfunction. The median PtGA was 13 (range 0-100, IQR 48), and the median PhGA was 4 (range 0-68, IQR 15). There was no association between VDI or activity scores and the presence of sexual dysfunction. Interestingly, the PtGA (-0.569, p< 0.001), the PhGA (-0.418, p=0.002), and the erythrocyte sedimentation rate (-0.37, p=0.01) negatively correlated with the CSFQ-14 score. Figure 1 displays the correlations of the CSFQ-14 score with other variables. After multivariate analysis, the only variables associated with sexual function according to the CSFQ-14 score were age (Exp B 1.076, 95% CI 1.004-1.154) and female sex (Exp B 4.76, 95% CI 1.006-22.56).

Conclusion: Sexual function is a critical but often overlooked aspect of patient care in systemic vasculitides. Despite the significant prevalence of sexual dysfunction among these patients, no direct correlation was found between specific disease parameters (activity and damage) and sexual function. Our study highlights the need for rheumatologists to proactively address sexual health during consultations as an integral component of patient well-being. 

Supporting image 1

Table 1. Characteristics of patients with and without sexual dysfunction

Supporting image 2

Figure 1. Correlation heat plot of the CSFQ14 and other outcome measures


Disclosures: j. Merayo Chalico: None; A. Mulia-Soto: None; M. Espinosa-León: None; V. Pimentel-Quiroz: None; A. Barrera-Vargas: None; A. Hinojosa-Azaola: None.

To cite this abstract in AMA style:

Merayo Chalico j, Mulia-Soto A, Espinosa-León M, Pimentel-Quiroz V, Barrera-Vargas A, Hinojosa-Azaola A. Impact of Systemic Vasculitides on Sexual Function: An Overlooked Aspect of Patient Care [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/impact-of-systemic-vasculitides-on-sexual-function-an-overlooked-aspect-of-patient-care/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-systemic-vasculitides-on-sexual-function-an-overlooked-aspect-of-patient-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology